(Disruption Interruption: Tampa Bay, FL) -- Bringing a new drug from discovery to market is a grueling marathon that typically requires 10-15 years of research, testing, and regulatory approval. According to recent data, clinical development times for innovative drugs have remained stagnant during the last decade, with a median duration of around 8 years.

Jurek Kozyra, founder and CEO of Nanovery, sat down with host Karla Jo Helms on the latest episode of the Disruption Interruption podcast to explain how he is dismantling these barriers. Kozyra discussed how the convergence of DNA nanotechnology and AI is creating a new era of “oligo therapeutics” capable of targeting the underlying mechanisms of disease.

 …